Virax Biolabs Group (Virax Biolabs Group) Median PS Value : $0.00 (As of Apr. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Virax Biolabs Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.435. Virax Biolabs Group's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-04-26), Virax Biolabs Group's share price is $0.70. Virax Biolabs Group's Median PS Value is $0.00. Therefore, Virax Biolabs Group's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Virax Biolabs Group's Median PS Value or its related term are showing as below:

VRAX's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.66
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Virax Biolabs Group Median PS Value Historical Data

The historical data trend for Virax Biolabs Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Median PS Value Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Median PS Value

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Median PS Value	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Virax Biolabs Group's Median PS Value

For the Biotechnology subindustry, Virax Biolabs Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virax Biolabs Group's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's Price-to-Median-PS-Value falls into.

Virax Biolabs Group Median PS Value Calculation

Virax Biolabs Group's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.435	*	0
	=	0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Virax Biolabs Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.435.

Virax Biolabs Group (NAS:VRAX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Virax Biolabs Group's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.70	/	0.00
	=

Virax Biolabs Group Median PS Value Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group (Virax Biolabs Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 North Audley Street, London, GBR, W1K 6LX

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.